Kyndryl and the University of Liverpool's Civic Health Innovation Labs (CHIL), will collaborate to explore how emerging AI technologies could be utilized to strengthen future healthcare services. Through the initiative, Kyndryl and the University plan to co-develop blueprints for next-generation healthcare technologies, using Kyndryl's Agentic AI Framework and the University's research expertise. In phase one, the collaboration aims to generate and evaluate conceptual AI projects with the potential to evolve and improve patient interaction.
Potential areas of collaboration include the development of conversational AI services, such as voice agents, to help patients record how they feel, how well they use medicines, and how to make the best use of the NHS and social care services. The projects launched under the collaboration between Kyndryl and theUniversity will contribute to a shared library of innovation-ready models for future use, and where appropriate will draw upon population health datasets and testbed environments such as Data-into-Action, CHI-Zone, Civic Data Cooperative, M-RIC, and SDE. Kyndryl's AI innovation lab in Liverpool, launched May 2025, will play a central role in the collaboration.
Drawing on the deep technical expertise of Kyndryl Consult in multi-agent optimization and conversational AI, the lab is designed to develop solutions that address many industries, including healthcare, by addressing real-world health challenges, particularly those faced by digitally excluded or underserved populations. The collaboration aligns with the Liverpool City Region'sLife Sciences Innovation Zone, part of the Government's national Investment Zone Programme, positioning the city region as a powerhouse for health and life sciences innovation.
